Terms: = Sarcomas AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808 AND Prognosis
12 results:
1. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
[No Abstract] [Full Text] [Related]
2. KAT6A::EP300 fusion in congenital myeloid sarcoma: Yet another novel molecular marker indicating spontaneous remission?: A case report.
Hosahalli Vasanna S; Shah SD; Rohr BR; Roche B; Meyerson H; Pateva I
Medicine (Baltimore); 2023 Jul; 102(30):e34258. PubMed ID: 37505185
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract] [Full Text] [Related]
4. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
[TBL] [Abstract] [Full Text] [Related]
5. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.
Dehner CA; Armstrong AE; Yohe M; Shern JF; Hirbe AC
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680895
[TBL] [Abstract] [Full Text] [Related]
6. [Extraskeletal mesenchymal chondrosarcoma in central nerve system: a clinicopathological analysis].
Wang YJ; Wang LM; Meng YH; Qi CH; Zhao LH; Lu DH; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1157-1162. PubMed ID: 34619870
[No Abstract] [Full Text] [Related]
7. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
[TBL] [Abstract] [Full Text] [Related]
8. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Characterization of Pediatric sarcomas by Targeted RNA Sequencing.
Avenarius MR; Miller CR; Arnold MA; Koo S; Roberts R; Hobby M; Grossman T; Moyer Y; Wilson RK; Mardis ER; Gastier-Foster JM; Pfau RB
J Mol Diagn; 2020 Oct; 22(10):1238-1245. PubMed ID: 32745614
[TBL] [Abstract] [Full Text] [Related]
10. Congenital spindle cell rhabdomyosarcoma.
Whittle SB; Hicks MJ; Roy A; Vasudevan SA; Reddy K; Venkatramani R
Pediatr Blood Cancer; 2019 Nov; 66(11):e27935. PubMed ID: 31339226
[TBL] [Abstract] [Full Text] [Related]
11. Soft tissue sarcomas: From a morphological to a molecular biological approach.
Oda Y; Yamamoto H; Kohashi K; Yamada Y; Iura K; Ishii T; Maekawa A; Bekki H
Pathol Int; 2017 Sep; 67(9):435-446. PubMed ID: 28759137
[TBL] [Abstract] [Full Text] [Related]
12. PAX3-ncoa2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells.
Yoshida H; Miyachi M; Sakamoto K; Ouchi K; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Imamura T; Iehara T; Kakazu N; Hojo H; Hosoi H
Oncogene; 2014 Dec; 33(49):5601-8. PubMed ID: 24213582
[TBL] [Abstract] [Full Text] [Related]
